IMPORTANCE OF ASCENDING DOPAMINERGIC SYSTEMS TO EXTRAPYRAMIDAL AND MESOLIMBIC BRAIN AREAS FOR CATALEPTIC ACTION OF NEUROLEPTIC AND CHOLINERGIC AGENTS

被引：57

作者：

COSTALL, B ^{[1
]}

NAYLOR, RJ ^{[1
]}

机构：

[1] UNIV BRADFORD, POSTGRAD SCH STUDIES PHARMACOL, BRADFORD BD7 1DP, YORKSHIRE, ENGLAND

来源：

NEUROPHARMACOLOGY | 1974年 / 13卷 / 05期

关键词：

D O I：

10.1016/0028-3908(74)90118-X

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：353 / 364

页数：12

共 32 条

[1] EFFECT OF CLOZAPINE ON TURNOVER OF DOPAMINE IN CORPUS STRIATUM AND IN LIMBIC SYSTEM [J].

ANDEN, N ;

STOCK, G .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (04) :346-348

[2]

Anden N-E, 1966, LIFE SCI, V5, P561

[3] RECEPTOR ACTIVITY AND TURNOVER OF DOPAMINE AND NORADRENALINE AFTER NEUROLEPTICS [J].

ANDEN, NE ;

BUTCHER, SG ;

CORRODI, H ;

FUXE, K ;

UNGERSTEDT, U .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1970, 11 (03) :303-+

[4]

Angst J., 1971, PHARMACOPSYCHIATRY, V4, P201

[5]

Angst J., 1971, PHARRNACKOPSYCHIATRI, V4, P192

[6] EFFECTS OF CLOZAPINE ON CEREBRAL CATECHOLAMINERGIC NEURON SYSTEMS [J].

BARTHOLINI, G ;

HAEFELY, W ;

JALFRE, M ;

KELLER, HH ;

PLETSCHER, A .

BRITISH JOURNAL OF PHARMACOLOGY, 1972, 46 (04) :736-740

[7]

BERZEWSKI H, 1969, ARZNEI-FORSCHUNG, V19, P495

[8] COMPARATIVE ACTIVITY OF ARECOLINE + ARECOLINE N-METHO SALT [J].

BURGEN, ASV .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1964, 16 (09) :638-&

[9]

CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140

[10]

CORRODI HANS, 1967, LIFE SCI, V6, P767, DOI 10.1016/0024-3205(67)90134-8

← 1 2 3 4 →